Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 25,258 | 3,728 | 689 | 897 | -4,618 |
| Cost of Goods | 3,279 | 1,320 | 395 | 220 | 132 |
| Gross Profit | 21,979 | 2,408 | 294 | 677 | -4,750 |
| Operating Expenses | 12,638 | 8,793 | 9,547 | 9,664 | 9,250 |
| Operating Income | 9,620 | -6,065 | -8,858 | -8,767 | -13,868 |
| Other Income | 22 | 161 | -55 | -108 | 179 |
| Pre-tax Income | 9,642 | -5,904 | -8,913 | -8,875 | -13,689 |
| Net Income Continuous | 9,642 | -5,904 | -8,913 | -8,875 | -13,689 |
| Net Income | $9,642 | $-5,904 | $-8,913 | $-8,875 | $-13,689 |
| EPS Basic Total Ops | 1.10 | -0.70 | -1.10 | -1.00 | -1.60 |
| EPS Basic Continuous Ops | 1.05 | -0.67 | -1.06 | -1.04 | -1.60 |
| EPS Diluted Total Ops | 1.00 | -0.70 | -1.10 | -1.00 | -1.60 |
| EPS Diluted Continuous Ops | 1.02 | -0.67 | -1.06 | -1.04 | -1.60 |
| EBITDA(a) | $10,550 | $-5,135 | $-7,925 | $-7,870 | $-12,945 |